Researchers at UC San Diego have developed SMART, a software package capable of realistically simulating cell-signaling networks. This tool, tested across various biological systems, enhances the unde ...
YolTech Therapeutics today announced updated data from its ongoing Phase I/IIa clinical trial of YOLT-201, a first-in-class CRISPR/Cas9-based in vivo gene-editing therapy for ATTR amyloidosis. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback